Latest filing published 14 Mar 2017 for Dexcom Inc, €875k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 22 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +37.6%Entry US$2.45 · Close at T+365 US$3.38
- +63.6%Entry US$1.90 · Close at T+365 US$3.11
- +142.7%Entry US$1.13 · Close at T+365 US$2.74
- +250.0%Entry US$0.50 · Close at T+365 US$1.75
- +279.0%Entry US$0.49 · Close at T+365 US$1.85
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jorge A. Valdes: trading record in brief
Jorge A. Valdes discloses dealings in Dexcom Inc to SEC (Form 4). In total, 202 filings cover trades dated from 26 July 2006 to 13 March 2017.
Both buying and selling appear: 22 purchases worth €121k, against 72 sales worth €45.7M. Netting one side against the other leaves €45.6M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 share grants and 48 option exercises. So far in 2017, the count stands at no purchases and 10 sales.
In size, the median ticket on the buying side is €2,445. After 22 purchases with a full 90-day history, the hit rate stands at 50% and the median 90-day move at +16.3%. These figures describe past trades and do not predict future prices.
The record was last updated on 14 March 2017 with a transaction (€875k) in Dexcom Inc. The last insider purchase was made public on 8 June 2010, 5,997 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jorge A. Valdes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,834 shares@ US$78.242.8% of flowCommon StockSEC:0001093557-17-000076:0
- 7,500 shares@ US$78.241.8% of flowCommon StockSEC:0001093557-17-000076:1
- 12,667 shares@ US$78.243.0% of flowCommon StockSEC:0001093557-17-000076:2
- 6,254 shares@ US$77.551.5% of flowCommon StockSEC:0001093557-17-000076:3
- 6,694 shares@ US$77.551.6% of flowCommon StockSEC:0001093557-17-000076:7
- 3,964 shares@ US$77.550.9% of flowCommon StockSEC:0001093557-17-000076:8
- 14,400 shares@ US$77.743.4% of flowCommon StockSEC:0001093557-17-000076:9
- 7,000 shares@ US$9.800.2% of flowCommon StockSEC:0001093557-17-000028:0
- 7,000 shares@ US$79.761.7% of flowCommon StockSEC:0001093557-17-000028:1
- 13,900 shares@ US$9.800.4% of flowCommon StockSEC:0001093557-17-000023:0
- 13,900 shares@ US$80.003.3% of flowCommon StockSEC:0001093557-17-000023:1
- 8,927 shares@ US$9.800.3% of flowCommon StockSEC:0001093557-17-000012:0
- 8,927 shares@ US$80.002.2% of flowCommon StockSEC:0001093557-17-000012:1
- 10,000 shares@ US$7.630.2% of flowCommon StockSEC:0001093557-17-000012:2
- 10,000 shares@ US$80.002.4% of flowCommon StockSEC:0001093557-17-000012:3
- 7,173 shares@ US$9.800.2% of flowCommon StockSEC:0001093557-17-000012:4
- 7,173 shares@ US$80.001.7% of flowCommon StockSEC:0001093557-17-000012:5
- 7,000 shares@ US$7.790.2% of flowCommon StockSEC:0001093557-17-000006:0
- 7,000 shares@ US$63.021.3% of flowCommon StockSEC:0001093557-17-000006:1
- 417 shares@ US$7.630.0% of flowCommon StockSEC:0001093557-17-000006:2
- 417 shares@ US$63.490.1% of flowCommon StockSEC:0001093557-17-000006:3
- 900 shares@ US$3.190.0% of flowCommon StockSEC:0001093557-17-000006:4
- 900 shares@ US$63.310.2% of flowCommon StockSEC:0001093557-17-000006:5
- 2,583 shares@ US$7.630.1% of flowCommon StockSEC:0001093557-17-000006:6
- 2,583 shares@ US$62.830.5% of flowCommon StockSEC:0001093557-17-000006:7
25 of 183 declarations
